Skip to content

Effect of Ciprofol and Remimazolam on Postoperative Fatigue in Patients Undergoing Lumbar Surgery: A Randomized Controlled Trial

Effect of Ciprofol and Remimazolam on Postoperative Fatigue in Patients Undergoing Lumbar Surgery: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109650
Enrollment
Unknown
Registered
2025-09-23
Start date
2025-05-28
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative fatigue syndrome (POFS) occurs in the recovery period of patients after surgery, mainly manifested as varying degrees of distraction, physical weakness, lack of subjective initiative, etc. Clinical symptoms are often exhaustion, muscle fatigue, body pain, physical exhaustion, gastrointestinal dysfunction and abnormal sleep.

Interventions

Group Ciprofol Injection:Using Cyclopholol intravenously for general anesthesia
Group Remimazolam:Using Cyclopholol intravenously for general anesthesia

Sponsors

Hefei First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Lumbar surgery; 2.General anesthesia; 3.ASA Grade I-II; 4.18.5kg/m^2<BMI<30kg/m^2.

Exclusion criteria

Exclusion criteria: 1.Patients with severe neurological disease resulting in limited limb movement; 2.Patients with Severe pulmonary hypertension, heart failure, liver and kidney insufficiency decompensated; 3.Persons with mental abnormalities or mental illness; 4.Persons Those allergic to clofibrate and remazolam; 5.Persons with severe hypotonia and central nervous system diseases before surgery; 6.Patients who had received other treatment in the last 6 months (at time of consent); 7.Patients who are judged to be lacking capacity for consent; 8.Patients who have recently taken analgesic and sedative drugs; 9.Patients judged by the attending physician or the attending physician in charge of the clinical department as inappropriate.

Design outcomes

Primary

MeasureTime frame
Christensen Fatigue Rating Score;

Secondary

MeasureTime frame
Levels of inflammatory factors: interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a) and C-reactive protein (CRP);Upper limb grip strength;VAS score;Time to get out of bed for the first time;

Countries

China

Contacts

Public ContactZhang Jing

Hefei First People's Hospital

709896023@qq.com+86 15805603962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026